Literature DB >> 12604778

Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease.

Sébastien Holbert1, Alpaslan Dedeoglu, Sandrine Humbert, Frédéric Saudou, Robert J Ferrante, Christian Néri.   

Abstract

Huntington's disease (HD) is a neurodegenerative disease caused by polyglutamine (polyQ) expansion in the protein huntingtin (htt). Pathogenesis in HD seems to involve the formation of neuronal intranuclear inclusions and the abnormal regulation of transcription and signal transduction. To identify previously uncharacterized htt-interacting proteins in a simple model system, we used a yeast two-hybrid screen with a Caenorhabditis elegans activation domain library. We found a predicted SH3 domain protein (K08E3.3b) that interacts with N-terminal htt in two-hybrid tests. A human homolog of K08E3.3b is the Cdc42-interacting protein 4 (CIP4), a protein involved in Cdc42 and Wiskott-Aldrich syndrome protein-dependent signal transduction. CIP4 interacted in vitro with full-length htt from lymphoblastoid cells. Neuronal CIP4 immunoreactivity increased with neuropathological severity in the neostriatum of HD patients and partially colocalized to ubiquitin-positive aggregates. Marked CIP4 overexpression also was observed in Western blot from human HD brain striatum. The overexpression of CIP4 induced the death of striatal neurons. Our data suggest that CIP4 accumulation and cellular toxicity may have a role in HD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604778      PMCID: PMC151406          DOI: 10.1073/pnas.0437967100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

Review 2.  Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.

Authors:  Christopher A Ross
Journal:  Neuron       Date:  2002-08-29       Impact factor: 17.173

3.  SH3 domain-dependent association of huntingtin with epidermal growth factor receptor signaling complexes.

Authors:  Y F Liu; R C Deth; D Devys
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

4.  Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease.

Authors:  Edmond Y W Chan; Ruth Luthi-Carter; Andrew Strand; Steven M Solano; Sarah A Hanson; Molly M DeJohn; Charles Kooperberg; Kathryn O Chase; Marian DiFiglia; Anne B Young; Blair R Leavitt; Jang-Ho J Cha; Neil Aronin; Michael R Hayden; James M Olson
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

5.  The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans.

Authors:  James F Morley; Heather R Brignull; Jill J Weyers; Richard I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

6.  Survey of CAG/CTG repeats in human cDNAs representing new genes: candidates for inherited neurological disorders.

Authors:  C Néri; V Albanèse; A S Lebre; S Holbert; C Saada; L Bougueleret; S Meier-Ewert; I Le Gall; P Millasseau; H Bui; C Giudicelli; C Massart; S Guillou; P Gervy; E Poullier; P Rigault; J Weissenbach; G Lennon; I Chumakov; J Dausset; H Lehrach; D Cohen; H M Cann
Journal:  Hum Mol Genet       Date:  1996-07       Impact factor: 6.150

Review 7.  The epidemiology of Huntington's disease.

Authors:  P S Harper
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

8.  Neuropathological classification of Huntington's disease.

Authors:  J P Vonsattel; R H Myers; T J Stevens; R J Ferrante; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1985-11       Impact factor: 3.685

9.  Diabetes mellitus in Huntington disease.

Authors:  L A Farrer
Journal:  Clin Genet       Date:  1985-01       Impact factor: 4.438

10.  Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons.

Authors:  M DiFiglia; E Sapp; K Chase; C Schwarz; A Meloni; C Young; E Martin; J P Vonsattel; R Carraway; S A Reeves
Journal:  Neuron       Date:  1995-05       Impact factor: 17.173

View more
  27 in total

1.  The F-BAR protein family Actin' on the membrane.

Authors:  Robert Fricke; Christina Gohl; Sven Bogdan
Journal:  Commun Integr Biol       Date:  2010-03

2.  BAR proteins in cancer and blood disorders.

Authors:  Yolande Chen; Jorie Aardema; Ashish Misra; Seth J Corey
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

3.  The F-BAR protein CIP4 inhibits neurite formation by producing lamellipodial protrusions.

Authors:  Witchuda Saengsawang; Kelly Mitok; Chris Viesselmann; Lauren Pietila; Derek C Lumbard; Seth J Corey; Erik W Dent
Journal:  Curr Biol       Date:  2012-02-21       Impact factor: 10.834

Review 4.  Gene-environment interactions: neurodegeneration in non-mammals and mammals.

Authors:  Michael Aschner; Edward D Levin; Cristina Suñol; James O Olopade; Kirsten J Helmcke; Daiana S Avila; Damiyon Sledge; Rahim H Ali; Lucia Upchurch; Susan Donerly; Elwood Linney; Anna Forsby; Padmavathi Ponnuru; James R Connor
Journal:  Neurotoxicology       Date:  2010-03-30       Impact factor: 4.294

5.  Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles.

Authors:  Adam Labadorf; Seung H Choi; Richard H Myers
Journal:  Front Mol Neurosci       Date:  2018-01-11       Impact factor: 5.639

6.  Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model.

Authors:  Sheng Zhang; Mel B Feany; Sudipta Saraswati; J Troy Littleton; Norbert Perrimon
Journal:  Dis Model Mech       Date:  2009-04-06       Impact factor: 5.758

7.  Genetic aspects of behavioral neurotoxicology.

Authors:  Edward D Levin; Michael Aschner; Ulrike Heberlein; Douglas Ruden; Kathleen A Welsh-Bohmer; Selena Bartlett; Karen Berger; Lang Chen; Ammon B Corl; Donnie Eddins; Rachael French; Kathleen M Hayden; Kirsten Helmcke; Helmut V B Hirsch; Elwood Linney; Greg Lnenicka; Grier P Page; Debra Possidente; Bernard Possidente; Annette Kirshner
Journal:  Neurotoxicology       Date:  2009-07-30       Impact factor: 4.294

Review 8.  Genetic and pharmacological suppression of polyglutamine-dependent neuronal dysfunction in Caenorhabditis elegans.

Authors:  J Alex Parker; Sébastien Holbert; Emmanuel Lambert; Salima Abderrahmane; Christian Néri
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's disease.

Authors:  Stefanie L Butland; Shaun S Sanders; Mandi E Schmidt; Sean-Patrick Riechers; David T S Lin; Dale D O Martin; Kuljeet Vaid; Rona K Graham; Roshni R Singaraja; Erich E Wanker; Elizabeth Conibear; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2014-04-04       Impact factor: 6.150

10.  AKAP350 interaction with cdc42 interacting protein 4 at the Golgi apparatus.

Authors:  M Cecilia Larocca; Ryan A Shanks; Lan Tian; David L Nelson; Donn M Stewart; James R Goldenring
Journal:  Mol Biol Cell       Date:  2004-03-26       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.